MontrealCanadaNorth and Central Amer icaAntigensBiological ProductsCOVID-19CoronavirusCyborgsEmerging Tec hnologiesEpitopesHealth and MedicineImmunizationImmunologyMachine Lear ningMedical DevicesRNA VirusesSARS-CoV-2Severe Acute Respiratory Syndrom e Coronavirus 2VaccinationVaccine DevelopmentVaccinesViralVirology
2024